GTR Test Accession:
Help
GTR000500486.2
CAP
Last updated in GTR:
2023-01-11
View version history
GTR000500486.2,
last updated:
2023-01-11
GTR000500486.1,
registered in GTR:
2019-12-30
Last annual review date for the lab: 2024-01-12
LinkOut
At a Glance
Test purpose:
Help
Diagnosis
Conditions (2):
Help
Duchenne muscular dystrophy;
Elevated circulating creatine kinase concentration
Genes (1):
Help
DMD (Xp21.2-21.1)
Methods (2):
Help
Molecular Genetics - Deletion/duplication analysis: Microarray; ...
Target population: Help
Male patients with suspected dystrophinopathy
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Test short name:
Help
DMD Deletion analysis
Specimen Source:
Help
- Amniocytes
- Amniotic fluid
- Cell culture
- Chorionic villi
- Cord blood
- Fibroblasts
- Isolated DNA
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Physician
Test Order Code:
Help
DMD Gene Deletion Analysis
View other test codes
View other test codes
CPT codes:
Help
Lab contact:
Help
Neda Zadeh, MD, ABMGG Board Certified, ABP, Diplomate of the American Board of M, Lab Director
nzadeh@geneticscenter.com
714-288-3500
nzadeh@geneticscenter.com
714-288-3500
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Test service:
Help
Clinical Testing/Confirmation of Mutations Identified Previously
Custom Deletion/Duplication Testing
Genetic counseling
Custom Deletion/Duplication Testing
Genetic counseling
Test additional service:
Help
Custom Prenatal Testing
Test development:
Help
Test developed by laboratory (no manufacturer test name)
Informed consent required:
Help
Yes
Pre-test genetic counseling required:
Help
No
Post-test genetic counseling required:
Help
No
Recommended fields not provided:
Test strategy
Conditions
Help
Total conditions: 2
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 1
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 2
Method Category
Help
Test method
Help
Instrument *
Deletion/duplication analysis
Microarray
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis
Target population:
Help
Male patients with suspected dystrophinopathy
Recommended fields not provided:
Clinical validity,
Clinical utility,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Platform:
None/not applicable
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
99 -per CAP requirements
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
College of American Pathologists, CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
College of American Pathologists, CAP
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Clinical resources:
Molecular resources:
Practice guidelines:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.